HyperCard 10 mg Coated Tablets for Cats

Ülke: İrlanda

Dil: İngilizce

Kaynak: HPRA (Health Products Regulatory Authority)

Aktif bileşen:

Diltiazem

Mevcut itibaren:

Dechra Ltd

ATC kodu:

QC08DB01

INN (International Adı):

Diltiazem

Doz:

10 mg/tablet

Farmasötik formu:

Coated tablet

Reçete türü:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapötik grubu:

Cats

Terapötik alanı:

diltiazem

Terapötik endikasyonlar:

Cardiovascular

Yetkilendirme durumu:

Authorised

Yetkilendirme tarihi:

2008-11-10

Ürün özellikleri

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
HyperCard 10mg Coated Tablets for Cats.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Coated tablet.
A yellow coated biconvex tablet.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the therapeutic treatment of feline primary hypertrophic
cardiomyopathy
4.3 CONTRAINDICATIONS
Do not use in animals suffering from AV block (2nd or 3rd),
hypotension or sick sinus syndrome.
Diltiazem should not be given to patients suffering from hepatic
disease.
Do not use in animals suffering from renal disease.
Do not use in cats less than 12 months old.
Do not use in cats weighing less than 3kg.
Do not use in animals that are hypersensitive to Diltiazem.
Do not use in cats with severe bradycardia or arterial hypotension.
Do not use in conjunction with
blockers, digitalis or digoxin.
Do not use in pregnant or lactating females.
Each tablet contains:
ACTIVE SUBSTANCE
Dilitazem
9.20 mg
(equivalent to 10 mg of
Diltiazem Hydrochloride)
EXCIPIENTS
Tartrazine (E102)
0.11 mg
Titanium Dioxide (E171)
1.1
mg
For a full list of excipients, see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_9_
_/_
_1_
_0_
_/_
_2_
_0_
_1_
_5_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_1_
_9_
_4_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS